Health Policy Council

Launched in April 2020, the Health Policy Council is composed of a diverse cross-section of our members who come together to exchange ideas, inform OCC priorities, and provide government with timely recommendations.

Although the Council was in development prior to the COVID-19 crisis, now more than ever, the participating members’ direction will be critical to support the health care system today and lead recovery tomorrow.

Founding members of the Council include:

• Abbott Laboratories
• AbbVie
• Accerta
• Adherium
• Amgen
• AstraZeneca
• BioMarin
• Boehringer Ingelheim
• Canadian Medical Association
• Eli Lilly
• GSK
• IMC
• Ingersoll Nurse Practitioner Led Clinic
• Janssen/J&J
• LifeLabs
• Medavie
• Medtronic
• Merck
• Ontario Genomics
• Ontario Medical Association
• Roche
• Servier
• Sun Life
• Trudell Medical

Click here to learn more about the OCC’s ongoing advocacy work.

Click here to learn more about the OCC’s COVID-19 related advocacy.

For more information on how to join the Council, please contact Ashley Challinor, Vice President of Policy.